H

Huaxia Eye Hospital Group Co Ltd
SZSE:301267

Watchlist Manager
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Watchlist
Price: 20.18 CNY -0.1% Market Closed
Market Cap: 17B CNY
Have any thoughts about
Huaxia Eye Hospital Group Co Ltd?
Write Note

Huaxia Eye Hospital Group Co Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Huaxia Eye Hospital Group Co Ltd
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
PP&E Net
ÂĄ1.5B
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
PP&E Net
ÂĄ3.1B
CAGR 3-Years
31%
CAGR 5-Years
23%
CAGR 10-Years
N/A
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
PP&E Net
ÂĄ9.9B
CAGR 3-Years
17%
CAGR 5-Years
37%
CAGR 10-Years
32%
Hengkang Medical Group Co Ltd
SZSE:002219
PP&E Net
ÂĄ2.7B
CAGR 3-Years
6%
CAGR 5-Years
2%
CAGR 10-Years
25%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
PP&E Net
ÂĄ8.1B
CAGR 3-Years
-3%
CAGR 5-Years
14%
CAGR 10-Years
18%
S
Sanbo Hospital Management Group Ltd
SZSE:301293
PP&E Net
ÂĄ769m
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Huaxia Eye Hospital Group Co Ltd
Glance View

Market Cap
17B CNY
Industry
Health Care

Huaxia Eye Hospital Group Co Ltd has positioned itself as a key player in China’s healthcare landscape, specializing in comprehensive ophthalmic services. Emerging from the early stirrings of China's reforms in the healthcare sector, Huaxia capitalized on a burgeoning demand for specialized medical care. With roots tracing back to when accessible eye care was a luxury in China, Huaxia recognized the immense potential in providing quality eye treatments. As the country urbanized rapidly, vision ailments became increasingly prevalent, creating a vast market for ocular health services. Huaxia seized this opportunity by establishing a network of state-of-the-art facilities across major cities, providing services ranging from basic eye examinations to complex surgeries. The company's revenue model is built on a multifaceted approach, combining patient volume with specialized treatments. Catering to a diverse demographic, Huaxia offers tiered service options that suit various financial capacities, ensuring a steady stream of income. Beyond individual consultations, the company has fostered partnerships with corporations and insurance providers, further securing a stable client base. Moreover, Huaxia invests significantly in pioneering medical technology and staff training, enhancing its reputation and thereby drawing more patients seeking top-notch care. Through strategic expansion and consistently leveraging advancements in ophthalmology, Huaxia Eye Hospital Group Co Ltd has solidified its place not just as a healthcare provider, but as a critical architect shaping the future of eye care in China.

Intrinsic Value
30.66 CNY
Undervaluation 34%
Intrinsic Value
Price
H

See Also

What is Huaxia Eye Hospital Group Co Ltd's PP&E Net?
PP&E Net
1.5B CNY

Based on the financial report for Dec 31, 2023, Huaxia Eye Hospital Group Co Ltd's PP&E Net amounts to 1.5B CNY.

What is Huaxia Eye Hospital Group Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 3Y
24%

Over the last year, the PP&E Net growth was 11%. The average annual PP&E Net growth rates for Huaxia Eye Hospital Group Co Ltd have been 24% over the past three years .

Back to Top